I decode the language of chromatin — using machine learning and statistical genomics to understand how cells regulate their genes.
From sequencing reads to biological insight — I build the pipelines, models, and visualizations that bridge the gap.
From Duke's genome center to drug discovery in San Diego.
I completed my PhD in Computational Biology and Bioinformatics at Duke University in the MacAlpine Lab (co-advised by Alex Hartemink), where I studied chromatin-mediated mechanisms of gene regulation and transcription.
I'm now applying those skills at Vividion Therapeutics, building computational approaches to accelerate therapeutic discovery.